Multicenter Study to Evaluate Efficacy, Tolerability, Safety of Derinat
Status:
Not yet recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
This multicenter prospective double blinded placebo-controlled randomized study is designed
to to evaluate clinical efficacy, tolerability and safety of medical product Derinat®,
solution for external and local use 0.25% in acute infections of respiratory system in
children